顯示第 65 至 80 項結果，共 106 項
-
Anti-Lipopolysaccharides Ogawa and Inaba [72.1] (Ab00349-5.0-BT)
-
Anti-Lipopolysaccharides Ogawa and Inaba [72.1] (Ab00349-5.0)
-
Anti-Lipopolysaccharides Ogawa and Inaba [72.1] (Ab00349-5.3-BT)
-
Anti-Lipopolysaccharides Ogawa and Inaba [72.1] (Ab00349-5.3)
-
Anti-MARCO [PLK1] (Ab01384-5.0-BT)
-
Anti-MARCO [PLK1] (Ab01384-5.0)
-
Anti-MUC1 [C595] (Ab02842-5.0-BT)
-
Anti-MUC1 [C595] (Ab02842-5.0)
-
Anti-Phosphatidylinositol-3,4-diphosphate [8C2] (Ab01220-5.0-BT)
-
Anti-Phosphatidylinositol-3,4-diphosphate [8C2] (Ab01220-5.0)
-
Anti-SARS-CoV S glycoprotein [Lsc18] (Ab01993-12.1-BT)
-
Anti-SARS-CoV S glycoprotein [Lsc18] (Ab01993-12.1)
-
Anti-SARS-CoV S glycoprotein [S110] (Ab00257-12.1-BT)
-
Anti-SARS-CoV S glycoprotein [S124] (Ab00258-12.1-BT)
-
Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17] (Ab02382-12.1-BT)
-
Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17] (Ab02382-12.1)